Frequency Therapeutics

$28.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.43 (+5.22%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours

Why Robinhood?

You can buy or sell FREQ and other stocks, options, and ETFs commission-free!

About FREQ

Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA. The listed name for FREQ is Frequency Therapeutics, Inc. Common Stock.

CEO
David L. Lucchino
Employees
47
Headquarters
Woburn, Massachusetts
Founded
2014
Market Cap
973.25M
Price-Earnings Ratio
Dividend Yield
Average Volume
218.36K
High Today
$28.90
Low Today
$26.89
Open Price
$27.40
Volume
131.35K
52 Week High
$29.71
52 Week Low
$14.50

Collections

FREQ Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 25, Pre-Market

You May Also Like